Clinical trial failures are common and costly, yet they can teach us important lessons.

Clinical trials held in the UK have seen patient enrollment and trial numbers drop. Flexibility & creativity are needed to overcome issues.

Blood-based biomarkers (BBMs) hold promise for a fast, convenient, and simple means to accurately diagnose Alzheimer's Disease.